Key result
Women with valvular heart disease face frequent diagnostic and treatment delays from atypical presentations.
Why the study?
Valvular heart disease exhibits significant sex and gender differences affecting presentation, diagnosis, treatment, and outcomes, with gaps in evidence and awareness regarding sex-specific considerations.
Answers are grounded in this paper and cite their sources.
Women with valvular heart disease often present with more advanced disease and experience delays in care due to biological, sociocultural, and systemic biases, highlighting the need for sex-specific research and guidelines.
Valvular heart disease (VHD) exhibits significant differences between sexes affecting disease presentation, diagnosis, treatment, and outcomes. Biological factors such as hormonal influences and anatomical variations contribute to differences in valve pathology and response to interventions. Sociocultural factors, including healthcare access and provider bias, further impact care delivery. Women often present with more advanced valvular heart disease and experience delays in referral and treatment related to differing symptomatology, lack of evidence and awareness regarding sex-specific considerations, and diagnostic criteria and treatment guidelines built on evidence lacking sex and gender diversity. Addressing these gaps through inclusive research and personalized care is essential for improving equity in cardiovascular outcomes.
No takes yet. Share an insight, caveat, or question.
Eckstein et al. (2026) conducted a review in Valvular heart disease. Sex and gender differences was evaluated. Women with valvular heart disease often present with more advanced disease and experience delays in referral and treatment due to differing symptomatology and lack of sex-specific evidence.
Synapse has enriched 10 related papers. Consider them for comparative context: